Results 121 to 130 of about 18,638 (158)

Cutaneous Leishmaniasis in the Immunocompromised: Diagnostic and Therapeutic Insights from a Case Documented in Central Italy. [PDF]

Infect Dis Rep
Povolo L, Barbiero A, Spinicci M, Petrosillo N, Bartoloni A, Zammarchi L.   +5 more
europepmc   +1 more source

Investigating the Effects of Demographic Factors on the Prevalence of Cutaneous Leishmaniasis in a Focus Area of Northeastern Iran. [PDF]

J Trop Med
Rajabi Gharaii F, Boroomand M, Mohammadpour A, Motamed-Jahromi M, Soltani A.   +4 more
europepmc   +1 more source

The Safety and Efficacy of an Immunomodulator Garlic-Based Cream (LeishG1) for Treating Uncomplicated Cutaneous Leishmaniasis: A Single-Blind, Multi-Center Study. [PDF]

Health Sci Rep
Emadi F, Khodashenas Z, Rashidi A, Khamesipour A, Zaboli M, Ghafourian M, Naghizadeh MM, Tuserkani F, Ghazanfari T.   +8 more
europepmc   +1 more source

Tropistry: A registry-based modular platform to improve care of neglected tropical diseases in nonendemic settings-Study protocol with two targeted conditions: acute schistosomiasis and cutaneous/mucocutaneous leishmaniasis. [PDF]

PLoS One
Bea-Serrano C, Alcedo S, Berens-Riha N, van Henten S, van Griensven J, Van Den Broucke S, Soentjens P, Gobbi F, Bottieau E.   +8 more
europepmc   +1 more source

Cutaneous leishmaniasis.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cutaneous Leishmaniasis

Journal of Special Operations Medicine, 2021
Leishmaniasis is a parasitic infection that can involve the skin, mucosal membranes, and internal organs. Soldiers are at highrisk of leishmaniasis when conducting operations in endemic regions. Medical providers should have a low threshold to consider Leishmaniasis as the cause of persisting skin lesions.
Elena M, Crecelius, Mark W, Burnett
openaire   +2 more sources